Zhejiang Aorui Te Pharmaceutical

Aurisco Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of complex Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is globally recognized for its expertise in steroid hormones, respiratory treatments, and cardiovascular medications, maintaining a robust portfolio of high-quality generic APIs. Aurisco operates multiple manufacturing sites that are GMP-compliant and have successfully passed inspections by the US FDA, EDQM, and other major regulatory agencies. In addition to its core API business, the company has expanded into the CDMO sector, offering specialized services in oligonucleotide and peptide synthesis to support innovative drug development. Aurisco is publicly traded on the Shanghai Stock Exchange and continues to grow its international footprint through strategic partnerships and advanced manufacturing capabilities.